Organon & Co | OGN - PE Price to Earnings


Organon & Co reported 3.75 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Celltrion 50.09 23.24 Sep/2025
Cspc Pharmaceutical 25.53 3.8 Sep/2025
Deva Holding AS 6.55 2.01 Sep/2023
Divis Laboratories Ltd 66.5 5.69 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Glaxosmithkline 11.93 6.46 Sep/2025
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 91.09 0.73 Sep/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Merck 13.92 5.08 Dec/2025
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Novartis 16.05 2.92 Sep/2025
Organigram Holdings 235 224.49 Sep/2025
Organon & Co 3.75 0.87 Dec/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 17.41 29.74 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Sartorius 34.42 122.1 Sep/2025
Sino Biopharmaceutical 17.03 0.89 Jun/2025